glp-1 agonists cancer risk Receptor in Breast Cancer: A New Frontier in Obesity and Prognosis Management The effect of GLP-1R agonists

GIP and GLP- 1 have opposing effects on glucagon release, despite their similarities

49 OuryF.SumaraG.SumaraO.FerronM.ChangH.SmithC

3 Reduced risk for breast cancer was similar in women both with and without diabetes and among both Black and White women

Currently Available Incretin-based Therapies 3,4 Abbreviations: DPP-4 = dipeptidyl peptidase-4

Glycemic indexes (A1C, fasting blood glucose) and kidney function should be monitored during initiation of therapy and routinely throughout the treatment plan

At what point will you contact your provider to discuss accelerating your semaglutide titration or implementing additional interventions